Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul 26:7:83.
doi: 10.1186/1471-2334-7-83.

T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals

Affiliations

T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals

Valérie Martinez et al. BMC Infect Dis. .

Abstract

Background: The identification of antigens able to differentiate tuberculosis (TB) disease from TB infection would be valuable. Cellular and humoral immune responses to Erp (Exported repetitive protein)--a recently identified M. tuberculosis protein--have not yet been investigated in humans and may contribute to this aim.

Methods: We analyzed the cellular and humoral immune responses to Erp, ESAT-6, Ag85B and PPD in TB patients, in BCG+ individuals without infection, BCG+ individuals with latent TB infection (LTBI) and BCG- controls. We used lymphoproliferation, ELISpot IFN-gamma, cytokine production assays and detection of specific human antibodies against recombinant M. tuberculosis proteins.

Results: We included 22 TB patients, 9 BCG+ individuals without TB infection, 7 LTBI and 7 BCG- controls. Erp-specific T cell counts were higher in LTBI than in the other groups. Erp-specific T cell counts were higher in LTBI subjects than TB patients (median positive frequency of 211 SFC/106 PBMC (range 118-2000) for LTBI subjects compared to 80 SFC/106 PBMC (range 50-191), p = 0.019); responses to PPD and ESAT-6 antigens did not differ between these groups. IFN-gamma secretion after Erp stimulation differed between TB patients and LTBI subjects (p = 0.02). Moreover, LTBI subjects but not TB patients or healthy subjects produced IgG3 against Erp.

Conclusion: The frequencies of IFN-gamma-producing specific T cells, the IFN-gamma secretion and the production of IgG3 after Erp stimulation are higher in LTBI subjects than in TB patients, whereas PPD and ESAT-6 are not.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proliferative responses to the specific mycobacterial antigens, PPD, Erp, ESAT-6 and Ag85B were evaluated in 3 groups: BCG+ subjects without infection, with latent TB infection (LTBI) and in TB patients (TB), measured by lymphoproliferation assay. A logarithmic scale is used and horizontal bars indicate positive values.
Figure 2
Figure 2
Numbers of antigen-specific T cells in the 4 groups:non BCG-vaccinated controls (BCG-), BCG+ subjects without infection and with latent TB infection (LTBI), and in TB patients (TB), measured by ELISpot IFN-γ assay after stimulation with PPD, Erp, ESAT-6 and Ag85B. A logarithmic scale is used and horizontal bars indicate positive values.
Figure 3
Figure 3
Cytokine productions (IFN-γ or ●, TNF-α or ▲ and IL-10 or ■) were represented for the 3 groups: BCG+ subjects without infection, with latent TB infection (LTBI) and in TB patients (TB).
Figure 4
Figure 4
Subtypes of IgG were represented in column bar after Erp, ESAT-6 and Ag85B stimulation in the 4 groups: non BCG-vaccinated controls (BCG-), BCG+ subjects without infection, with latent TB infection (LTBI) and in TB patients (TB) in the order: IgG1, IgG2, IgG3, IgG4.

Similar articles

Cited by

References

    1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. Jama. 1999;282:677–686. doi: 10.1001/jama.282.7.677. - DOI - PubMed
    1. Chan J, Flynn J. The immunological aspects of latency in tuberculosis. Clin Immunol. 2004;110:2–12. doi: 10.1016/S1521-6616(03)00210-9. - DOI - PubMed
    1. Kaufmann SH. How can immunology contribute to the control of tuberculosis? Nat Rev Immunol. 2001;1:20–30. doi: 10.1038/35095558. - DOI - PubMed
    1. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol. 2001;19:93–129. doi: 10.1146/annurev.immunol.19.1.93. - DOI - PubMed
    1. Andersen P, Andersen AB, Sorensen AL, Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol. 1995;154:3359–3372. - PubMed

MeSH terms